Curaleaf Rolls Out Medical Pot Products in Germany
A day after reporting its latest set of quarterly results, Curaleaf Holdings (OTC: CURLF) announced a promising new product line in a market far from its own. On Tuesday, the U.S. cannabis company said a subsidiary has launched a new line of medical marijuana products in Germany.
That subsidiary, Adven, is rolling out a high-Tetrahydrocannabinol (THC; the substance that produces pot's famous euphoria) oil product to introduce the country to its offerings. This will be followed by other products of varying strengths in both oil and flower formats. Curaleaf/Adven is also to introduce cannabidiol (CBD) formulations for qualifying German patients.
Image source: Getty Images.
Source Fool.com
